VERICIGUAT

VERICIGUAT was reported 994 times

VERICIGUAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUSCLE RELAXANT THERAPY 1 0.0588
1 SUBCLAVIAN VEIN OCCLUSION 1 0.0417
2 NECROTISING FASCIITIS STAPHYLOCOCCAL 1 0.0333
3 CARDIAC RESYNCHRONISATION THERAPY 2 0.0282
4 NEURONE-SPECIFIC ENOLASE INCREASED 1 0.0233
5 DIURETIC THERAPY 1 0.0139
6 EJECTION FRACTION ABNORMAL 13 0.0106
7 INCREASED DOSE ADMINISTERED 3 0.0096
8 LEFT ATRIAL APPENDAGE CLOSURE IMPLANT 1 0.0090
9 FOREIGN BODY INGESTION 1 0.0089
10 HYPOTENSIVE CRISIS 1 0.0069
11 PROSOPAGNOSIA 1 0.0063
12 DILATED CARDIOMYOPATHY 6 0.0059
13 PICA 1 0.0056
14 CONJUNCTIVAL PALLOR 1 0.0055
15 IMMOBILISATION SYNDROME 1 0.0047
16 BRAIN NATRIURETIC PEPTIDE ABNORMAL 1 0.0047
17 THROMBOLYSIS 1 0.0045
18 CARDIAC SARCOIDOSIS 1 0.0043
19 ACETONAEMIA 1 0.0040
20 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
21 SECONDARY HYPERTENSION 1 0.0035
22 SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0033
23 VENTRICULAR FAILURE 1 0.0032
24 ANTICOAGULATION DRUG LEVEL INCREASED 1 0.0031
25 ANALGESIC THERAPY 1 0.0031
26 COLORECTAL ADENOMA 1 0.0031
27 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
28 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
29 LOW CARDIAC OUTPUT SYNDROME 1 0.0030
30 INGUINAL HERNIA REPAIR 1 0.0030
31 GAS GANGRENE 1 0.0029
32 VENOUS PRESSURE JUGULAR INCREASED 1 0.0028
33 SYMPTOM MASKED 2 0.0027
34 BLOOD PRESSURE SYSTOLIC DECREASED 11 0.0024
35 NEUROSIS 1 0.0022
36 CORONARY ANGIOPLASTY 1 0.0022
37 CEREBRAL ARTERY STENOSIS 1 0.0020
38 PULSE PRESSURE DECREASED 1 0.0020
39 CARDIAC FAILURE CHRONIC 8 0.0019
40 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
41 MORNING SICKNESS 1 0.0018
42 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
43 JUGULAR VEIN DISTENSION 1 0.0018
44 MECHANICAL ILEUS 1 0.0018
45 CARDIORENAL SYNDROME 1 0.0017
46 MEDIASTINITIS 1 0.0017
47 MITRAL VALVE CALCIFICATION 1 0.0016
48 PNEUMOCOCCAL SEPSIS 1 0.0015
49 IMPLANTABLE DEFIBRILLATOR INSERTION 2 0.0015
50 EMBOLIC CEREBRAL INFARCTION 1 0.0015
51 HEAT ILLNESS 1 0.0015
52 ISCHAEMIC HEPATITIS 2 0.0015
53 GRAVITATIONAL OEDEMA 1 0.0014
54 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
55 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
56 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
57 QRS AXIS ABNORMAL 1 0.0013
58 DEBRIDEMENT 1 0.0013
59 MYOPERICARDITIS 1 0.0013
60 POLYPECTOMY 1 0.0013
61 INCISION SITE HAEMORRHAGE 1 0.0012
62 PERITONEAL DIALYSIS 1 0.0012
63 AMAUROSIS 1 0.0012
64 VASOCONSTRICTION 1 0.0011
65 HEART TRANSPLANT 1 0.0011
66 THROMBOCYTOSIS 4 0.0011
67 VASOSPASM 1 0.0011
68 PRODUCT APPEARANCE CONFUSION 1 0.0011
69 BUNDLE BRANCH BLOCK 1 0.0011
70 CONCOMITANT DISEASE PROGRESSION 2 0.0010
71 HYPERVOLAEMIA 5 0.0010
72 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
73 CARDIAC FAILURE 77 0.0010
74 RESPIRATORY TRACT IRRITATION 1 0.0010
75 SUSPECTED OFF LABEL USE 4 0.0009
76 BLOOD LOSS ANAEMIA 2 0.0009
77 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
78 PRURITUS ALLERGIC 1 0.0009
79 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
80 CEREBRAL ARTERY EMBOLISM 1 0.0008
81 VENTRICULAR ARRHYTHMIA 3 0.0008
82 INFUSION SITE WARMTH 1 0.0008
83 AMPUTATION 1 0.0008
84 NOCTURNAL DYSPNOEA 1 0.0008
85 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
86 FEELINGS OF WORTHLESSNESS 1 0.0008
87 EXTRADURAL HAEMATOMA 1 0.0008
88 FUNGAL SKIN INFECTION 3 0.0007
89 CARDIOVERSION 1 0.0007
90 EJECTION FRACTION DECREASED 11 0.0007
91 MITRAL VALVE INCOMPETENCE 8 0.0007
92 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
93 INABILITY TO AFFORD MEDICATION 7 0.0007
94 PULMONARY VALVE INCOMPETENCE 1 0.0007
95 NORMOCYTIC ANAEMIA 1 0.0007
96 PNEUMONIA PNEUMOCOCCAL 1 0.0007
97 PALLIATIVE CARE 1 0.0007
98 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
99 LOCALISED OEDEMA 3 0.0006
100 BLOOD PRESSURE DECREASED 43 0.0006
101 FUNGAEMIA 1 0.0006
102 ORTHOPNOEA 2 0.0006
103 VENTRICULAR HYPOKINESIA 2 0.0006
104 BRADYARRHYTHMIA 1 0.0006
105 SUDDEN CARDIAC DEATH 2 0.0006
106 FIXED ERUPTION 1 0.0006
107 AMYLOIDOSIS 1 0.0006
108 BLOOD CREATININE ABNORMAL 2 0.0006
109 TREATMENT DELAYED 1 0.0006
110 HYPOTENSION 116 0.0006
111 VASCULAR PSEUDOANEURYSM 1 0.0006
112 AORTIC VALVE STENOSIS 1 0.0006
113 PRODUCT PRESCRIBING ISSUE 12 0.0006
114 DISORGANISED SPEECH 1 0.0005
115 CARDIAC DYSFUNCTION 2 0.0005
116 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
117 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
118 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
119 CARDIAC DISCOMFORT 1 0.0005
120 LIBIDO INCREASED 1 0.0005
121 NIPPLE PAIN 1 0.0005
122 HYPERURICAEMIA 2 0.0005
123 HYPERPARATHYROIDISM 1 0.0005
124 VENTRICULAR TACHYCARDIA 8 0.0005
125 INSULIN RESISTANCE 1 0.0005
126 ATRIAL TACHYCARDIA 1 0.0005
127 EYE CONTUSION 1 0.0005
128 PRODUCT DISPENSING ISSUE 2 0.0005
129 PRODUCT PREPARATION ISSUE 3 0.0005
130 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
131 RESPIRATORY RATE INCREASED 4 0.0005
132 GASTRIC POLYPS 1 0.0004
133 RENAL COLIC 1 0.0004
134 GASTRITIS EROSIVE 2 0.0004
135 CARDIOGENIC SHOCK 6 0.0004
136 HOSPICE CARE 4 0.0004
137 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
138 VULVOVAGINAL PRURITUS 2 0.0004
139 COMPARTMENT SYNDROME 1 0.0004
140 TRICUSPID VALVE INCOMPETENCE 3 0.0004
141 VENTRICULAR FIBRILLATION 4 0.0004
142 DRUG TOLERANCE DECREASED 1 0.0004
143 CEREBRAL THROMBOSIS 1 0.0004
144 PRODUCT AVAILABILITY ISSUE 8 0.0004
145 DUODENAL ULCER HAEMORRHAGE 1 0.0003
146 RALES 2 0.0003
147 STRESS CARDIOMYOPATHY 2 0.0003
148 BILIARY COLIC 1 0.0003
149 HEAD DISCOMFORT 6 0.0003
150 CARDIOMYOPATHY 5 0.0003
151 DUODENITIS 1 0.0003
152 FIBROSIS 1 0.0003
153 INFUSION SITE PRURITUS 1 0.0003
154 ILL-DEFINED DISORDER 19 0.0003
155 HAEMOGLOBIN ABNORMAL 2 0.0003
156 DIZZINESS POSTURAL 3 0.0003
157 PULMONARY CONGESTION 4 0.0003
158 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
159 CARDIAC FAILURE ACUTE 2 0.0003
160 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
161 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
162 LYMPHOEDEMA 2 0.0003
163 VENTRICULAR EXTRASYSTOLES 3 0.0003
164 AORTIC STENOSIS 1 0.0003
165 SCRATCH 3 0.0003
166 RENAL PAIN 3 0.0003
167 HAEMORRHAGIC DIATHESIS 1 0.0003
168 NO ADVERSE EVENT 49 0.0003
169 WOUND HAEMORRHAGE 1 0.0003
170 FAECES HARD 1 0.0003
171 HYPERKALAEMIA 9 0.0003
172 CEREBRAL ATROPHY 1 0.0003
173 OBSTRUCTION 1 0.0003
174 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
175 PERIPHERAL VENOUS DISEASE 1 0.0002
176 DRUG INTOLERANCE 23 0.0002
177 ALCOHOLISM 1 0.0002
178 ORTHOSTATIC HYPOTENSION 4 0.0002
179 JOINT STIFFNESS 6 0.0002
180 DIVERTICULUM INTESTINAL 1 0.0002
181 RENAL IMPAIRMENT 19 0.0002
182 CATHETERISATION CARDIAC 1 0.0002
183 URINARY TRACT DISORDER 1 0.0002
184 TACHYPNOEA 3 0.0002
185 UROSEPSIS 2 0.0002
186 IRON DEFICIENCY ANAEMIA 2 0.0002
187 NEPHROGENIC ANAEMIA 1 0.0002
188 PRODUCT DISTRIBUTION ISSUE 2 0.0002
189 DIARRHOEA HAEMORRHAGIC 2 0.0002
190 DIALYSIS 3 0.0002
191 BLOOD URINE PRESENT 4 0.0002
192 ANAEMIA 40 0.0002
193 BLOOD PRESSURE FLUCTUATION 5 0.0002
194 DERMATITIS EXFOLIATIVE 1 0.0002
195 DYSPHORIA 1 0.0002
196 CORONARY ARTERIAL STENT INSERTION 1 0.0002
197 CACHEXIA 1 0.0002
198 CEREBRAL ISCHAEMIA 1 0.0002
199 PERIPHERAL VASCULAR DISORDER 1 0.0002
200 PRODUCT DOSE OMISSION ISSUE 55 0.0002
201 DECREASED ACTIVITY 2 0.0002
202 BEHAVIOUR DISORDER 1 0.0002
203 BLOOD POTASSIUM INCREASED 3 0.0002
204 FAECES DISCOLOURED 4 0.0002
205 ADVERSE EVENT 17 0.0002
206 FAECALOMA 1 0.0002
207 THROAT IRRITATION 8 0.0002
208 SHOCK 4 0.0002
209 ELECTROLYTE IMBALANCE 2 0.0002
210 POST PROCEDURAL HAEMORRHAGE 2 0.0002
211 ACUTE MYOCARDIAL INFARCTION 5 0.0002
212 CATARACT OPERATION 1 0.0002
213 PROTHROMBIN TIME PROLONGED 1 0.0002
214 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
215 GANGRENE 1 0.0002
216 INGUINAL HERNIA 1 0.0002
217 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
218 DYSPEPSIA 16 0.0002
219 HYPERCALCAEMIA 2 0.0002
220 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
221 PRODUCT USE ISSUE 30 0.0002
222 FEELING JITTERY 3 0.0002
223 ANGINA UNSTABLE 1 0.0002
224 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
225 NEPHROLITHIASIS 7 0.0002
226 TERMINAL STATE 1 0.0001
227 WRONG PRODUCT ADMINISTERED 1 0.0001
228 ARRHYTHMIA 7 0.0001
229 INFARCTION 1 0.0001
230 LARGE INTESTINE POLYP 1 0.0001
231 EXTRASYSTOLES 1 0.0001
232 PRODUCT SUPPLY ISSUE 1 0.0001
233 SYNCOPE 14 0.0001
234 ANGINA PECTORIS 4 0.0001
235 OEDEMA PERIPHERAL 17 0.0001
236 PANIC REACTION 1 0.0001
237 DIZZINESS 69 0.0001
238 MOUTH HAEMORRHAGE 1 0.0001
239 MELAENA 3 0.0001
240 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
241 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
242 FEELING DRUNK 1 0.0001
243 ATRIAL FIBRILLATION 13 0.0001
244 BREAST TENDERNESS 1 0.0001
245 DYSPNOEA EXERTIONAL 5 0.0001
246 PEMPHIGOID 1 0.0001
247 PROCEDURAL COMPLICATION 1 0.0001
248 HOSPITALISATION 20 0.0001
249 ATRIOVENTRICULAR BLOCK 1 0.0001
250 HYPOALBUMINAEMIA 1 0.0001
251 TREATMENT NONCOMPLIANCE 7 0.0001
252 TORSADE DE POINTES 1 0.0001
253 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
254 ATRIAL FLUTTER 1 0.0001
255 NECK PAIN 7 0.0001
256 FRUSTRATION TOLERANCE DECREASED 1 0.0001
257 MUSCLE DISORDER 1 0.0001
258 PRESYNCOPE 3 0.0001
259 ASPHYXIA 1 0.0001
260 HICCUPS 1 0.0001
261 HYPERAESTHESIA 1 0.0001
262 SPINAL COMPRESSION FRACTURE 1 0.0001
263 EMBOLISM 1 0.0001
264 HEMIPLEGIA 1 0.0001
265 GAIT INABILITY 4 0.0001
266 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
267 INFUSION SITE ERYTHEMA 1 0.0001
268 FLUID RETENTION 6 0.0001
269 FACIAL PARALYSIS 1 0.0001
270 CARDIAC OPERATION 1 0.0001
271 CARDIAC MURMUR 1 0.0001
272 PYELONEPHRITIS 1 0.0001
273 SPINAL OSTEOARTHRITIS 1 0.0001
274 DEATH 98 0.0001
275 JAUNDICE 3 0.0001
276 ANAL INCONTINENCE 1 0.0001
277 OEDEMA 6 0.0001
278 CARDIAC ARREST 9 0.0001
279 PERSONALITY CHANGE 1 0.0001
280 BLOOD CREATININE INCREASED 7 0.0001
281 CARDIAC DISORDER 10 0.0001
282 ILLNESS 11 0.0001
283 ARTERIOSCLEROSIS 1 0.0001
284 LEUKAEMIA 1 0.0001
285 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
286 RECALLED PRODUCT ADMINISTERED 1 0.0001
287 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
288 AFFECT LABILITY 1 0.0001
289 ATELECTASIS 1 0.0001
290 HAEMORRHOIDS 2 0.0001
291 PALPITATIONS 12 0.0001
292 PHARYNGEAL SWELLING 1 0.0001
293 ASCITES 3 0.0001
294 LUNG DISORDER 5 0.0001
295 FULL BLOOD COUNT DECREASED 2 0.0001
296 EMPHYSEMA 1 0.0001
297 VERTIGO 6 0.0001
298 INITIAL INSOMNIA 1 0.0001
299 PULMONARY HYPERTENSION 2 0.0001
300 WEIGHT FLUCTUATION 1 0.0001
301 FULL BLOOD COUNT ABNORMAL 1 0.0001
302 LIVER FUNCTION TEST INCREASED 2 0.0001
303 SEPTIC SHOCK 4 0.0001
304 LIP SWELLING 3 0.0001
305 PANCYTOPENIA 5 0.0001
306 MALNUTRITION 1 0.0001
307 PULMONARY OEDEMA 4 0.0001
308 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
309 NEPHROPATHY TOXIC 1 0.0001
310 CARDIAC FAILURE CONGESTIVE 7 0.0001
311 METASTASES TO LUNG 1 0.0001
312 CHOLECYSTITIS 1 0.0001
313 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
314 HYPERLIPIDAEMIA 1 0.0001
315 ABDOMINAL DISCOMFORT 14 0.0001
316 CEREBRAL INFARCTION 2 0.0001
317 GENERALISED OEDEMA 1 0.0001
318 HEPATIC FUNCTION ABNORMAL 3 0.0001
319 TOOTH EXTRACTION 1 0.0001
320 LEUKOPENIA 4 0.0001
321 CHRONIC KIDNEY DISEASE 6 0.0001
322 HAEMATEMESIS 2 0.0001
323 HEPATIC CYTOLYSIS 1 0.0001
324 ACUTE KIDNEY INJURY 12 0.0001
325 ERECTILE DYSFUNCTION 2 0.0001
326 ROTATOR CUFF SYNDROME 1 0.0001
327 DRUG RESISTANCE 2 0.0001
328 GENITAL HAEMORRHAGE 1 0.0001
329 MALAISE 34 0.0001
330 HIATUS HERNIA 1 0.0001
331 ASTHENIA 29 0.0001
332 SARS-COV-2 TEST POSITIVE 1 0.0001
333 BRADYCARDIA 4 0.0001
334 FEELING ABNORMAL 18 0.0001
335 RASH PRURITIC 4 0.0001
336 PALLOR 2 0.0001
337 IMPAIRED GASTRIC EMPTYING 1 0.0001
338 PERIPHERAL COLDNESS 1 0.0001
339 DIVERTICULITIS 2 0.0001
340 FEELING COLD 2 0.0001
341 CARDIO-RESPIRATORY ARREST 3 0.0001
342 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
343 SKIN REACTION 1 0.0001
344 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
345 BRONCHOSPASM 1 0.0001
346 IMPAIRED QUALITY OF LIFE 1 0.0001
347 HYPERTHYROIDISM 1 0.0001
348 HYPOKINESIA 1 0.0001
349 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
350 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
351 URINARY INCONTINENCE 2 0.0001
352 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
353 PULMONARY MASS 1 0.0001
354 COLON CANCER 1 0.0001
355 THERAPY NON-RESPONDER 3 0.0001
356 HEPATIC FAILURE 2 0.0001
357 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
358 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
359 PLEURAL EFFUSION 4 0.0001
360 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
361 RENAL DISORDER 3 0.0001
362 SWOLLEN TONGUE 2 0.0001
363 BRAIN FOG 1 0.0001
364 DRUG-INDUCED LIVER INJURY 2 0.0001
365 DYSPNOEA 36 0.0001
366 PNEUMOTHORAX 1 0.0001
367 RESPIRATORY TRACT CONGESTION 1 0.0001
368 HALLUCINATION, AUDITORY 1 0.0001
369 METABOLIC ACIDOSIS 2 0.0001
370 HYPOGLYCAEMIA 3 0.0001
371 CHOLELITHIASIS 2 0.0001
372 COAGULOPATHY 1 0.0001
373 CHEST DISCOMFORT 6 0.0001
374 THERAPY CESSATION 3 0.0001
375 HAEMOGLOBIN DECREASED 6 0.0001
376 NIGHTMARE 2 0.0001
377 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
378 ABDOMINAL DISTENSION 6 0.0001
379 NERVOUSNESS 3 0.0001
380 COUGH 16 0.0001
381 HYPOXIA 2 0.0001
382 COLD SWEAT 1 0.0001
383 GASTROINTESTINAL DISORDER 5 0.0001
384 GOUT 1 0.0001
385 OSTEOMYELITIS 1 0.0001
386 SEPSIS 6 0.0001
387 HEPATIC STEATOSIS 1 0.0001
388 BACTERIAL INFECTION 1 0.0001
389 OXYGEN SATURATION DECREASED 3 0.0001
390 PHOTOPHOBIA 1 0.0001
391 CEREBROVASCULAR ACCIDENT 9 0.0001
392 INTESTINAL OBSTRUCTION 2 0.0001
393 FRACTURE 1 0.0001
394 MUSCULAR WEAKNESS 6 0.0001
395 URINARY TRACT INFECTION 9 0.0001
396 DEHYDRATION 7 0.0001
397 SLEEP APNOEA SYNDROME 1 0.0001
398 CHOLESTASIS 1 0.0001
399 ACUTE RESPIRATORY FAILURE 1 0.0001
400 ABDOMINAL PAIN 12 0.0001
401 ORAL HERPES 1 0.0001
402 VISION BLURRED 7 0.0001
403 SINUS DISORDER 1 0.0001
404 HEART RATE INCREASED 5 0.0001
405 RASH 22 0.0001
406 BLOOD PRESSURE ABNORMAL 1 0.0001
407 PRESCRIBED UNDERDOSE 1 0.0001
408 PRODUCT PHYSICAL ISSUE 1 0.0000
409 PRODUCT ADMINISTRATION ERROR 1 0.0000
410 TASTE DISORDER 1 0.0000
411 NEUTROPHIL COUNT DECREASED 2 0.0000
412 LUNG NEOPLASM MALIGNANT 2 0.0000
413 CHEST PAIN 9 0.0000
414 ABDOMINAL PAIN UPPER 10 0.0000
415 FATIGUE 37 0.0000
416 MOUTH ULCERATION 1 0.0000
417 POOR QUALITY SLEEP 1 0.0000
418 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
419 SWELLING FACE 3 0.0000
420 PRODUCT DISPENSING ERROR 1 0.0000
421 PERIPHERAL SWELLING 7 0.0000
422 ANGIOEDEMA 2 0.0000
423 RENAL FAILURE 6 0.0000
424 NEOPLASM MALIGNANT 3 0.0000
425 DIARRHOEA 29 0.0000
426 WEIGHT INCREASED 10 0.0000
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
428 MUSCLE TWITCHING 1 0.0000
429 PERICARDIAL EFFUSION 1 0.0000
430 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
431 WEIGHT DECREASED 12 0.0000
432 HYPERTENSION 9 0.0000
433 TREMOR 7 0.0000
434 PRODUCT PRESCRIBING ERROR 1 0.0000
435 URTICARIA 7 0.0000
436 JOINT SWELLING 5 0.0000
437 INTERSTITIAL LUNG DISEASE 2 0.0000
438 CONSTIPATION 9 0.0000
439 LIVER INJURY 1 0.0000
440 VOMITING 19 0.0000
441 EPISTAXIS 3 0.0000
442 HALLUCINATION 3 0.0000
443 CELLULITIS 2 0.0000
444 ABDOMINAL PAIN LOWER 1 0.0000
445 INCORRECT DOSE ADMINISTERED 9 0.0000
446 CARDIOVASCULAR DISORDER 1 0.0000
447 FLUSHING 4 0.0000
448 NAUSEA 31 0.0000
449 HYPOPHAGIA 1 0.0000
450 SPEECH DISORDER 2 0.0000
451 GASTRITIS 1 0.0000
452 PLATELET COUNT DECREASED 4 0.0000
453 PAIN OF SKIN 1 0.0000
454 CONFUSIONAL STATE 6 0.0000
455 PNEUMONITIS 1 0.0000
456 RESPIRATORY DISTRESS 1 0.0000
457 ABNORMAL DREAMS 1 0.0000
458 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
459 INTENTIONAL DOSE OMISSION 1 0.0000
460 HYPERSOMNIA 1 0.0000
461 DYSSTASIA 1 0.0000
462 SURGERY 2 0.0000
463 LABORATORY TEST ABNORMAL 1 0.0000
464 HEADACHE 21 0.0000
465 CORONARY ARTERY DISEASE 1 0.0000
466 BLOOD PRESSURE INCREASED 5 0.0000
467 FEMUR FRACTURE 1 0.0000
468 HEAD INJURY 1 0.0000
469 DRUG INTERACTION 5 0.0000
470 HYPOTHYROIDISM 1 0.0000
471 ALOPECIA 6 0.0000
472 BACK PAIN 7 0.0000
473 SKIN DISORDER 1 0.0000
474 EYE PRURITUS 1 0.0000
475 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
476 GASTRIC DISORDER 1 0.0000
477 DELIRIUM 1 0.0000
478 HAEMORRHAGE 3 0.0000
479 COVID-19 5 0.0000
480 HEART RATE DECREASED 1 0.0000
481 CEREBRAL HAEMORRHAGE 1 0.0000
482 PNEUMONIA 9 0.0000
483 C-REACTIVE PROTEIN INCREASED 1 0.0000
484 HYPERGLYCAEMIA 1 0.0000
485 PANIC ATTACK 1 0.0000
486 ACCIDENTAL OVERDOSE 1 0.0000
487 THROMBOCYTOPENIA 3 0.0000
488 HOT FLUSH 2 0.0000
489 DIABETES MELLITUS 2 0.0000
490 PRURITUS 10 0.0000
491 DISEASE PROGRESSION 3 0.0000
492 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
493 DISORIENTATION 1 0.0000
494 VISUAL IMPAIRMENT 3 0.0000
495 FALL 8 0.0000
496 POLLAKIURIA 1 0.0000
497 SKIN EXFOLIATION 2 0.0000
498 HYPOACUSIS 1 0.0000
499 MYOCARDIAL INFARCTION 4 0.0000
500 TINNITUS 1 0.0000
501 SKIN DISCOLOURATION 1 0.0000
502 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
503 DECREASED APPETITE 5 0.0000
504 COGNITIVE DISORDER 1 0.0000
505 SWELLING 2 0.0000
506 NEUROPATHY PERIPHERAL 2 0.0000
507 DISEASE RECURRENCE 1 0.0000
508 PRODUCTIVE COUGH 1 0.0000
509 AGGRESSION 1 0.0000
510 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
511 ECZEMA 1 0.0000
512 DEPRESSED MOOD 1 0.0000
513 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
514 INSOMNIA 5 0.0000
515 DISTURBANCE IN ATTENTION 1 0.0000
516 HAEMATOCHEZIA 1 0.0000
517 FLATULENCE 1 0.0000
518 LETHARGY 1 0.0000
519 EYE IRRITATION 1 0.0000
520 SEIZURE 2 0.0000
521 NASAL CONGESTION 1 0.0000
522 PAIN IN EXTREMITY 5 0.0000
523 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
524 HYPERSENSITIVITY 3 0.0000
525 GAIT DISTURBANCE 3 0.0000
526 LOSS OF CONSCIOUSNESS 2 0.0000
527 HYPERHIDROSIS 2 0.0000
528 RHINORRHOEA 1 0.0000
529 DEEP VEIN THROMBOSIS 1 0.0000
530 AMNESIA 1 0.0000
531 PSORIASIS 2 0.0000
532 INFUSION RELATED REACTION 1 0.0000
533 DRY SKIN 2 0.0000
534 SOMNOLENCE 3 0.0000
535 OFF LABEL USE 13 0.0000
536 HEPATIC ENZYME INCREASED 1 0.0000
537 MEMORY IMPAIRMENT 2 0.0000
538 ANXIETY 4 0.0000
539 THERAPY INTERRUPTED 1 0.0000
540 MOBILITY DECREASED 1 0.0000
541 RESPIRATORY FAILURE 1 0.0000
542 UNDERDOSE 1 0.0000
543 AGITATION 1 0.0000
544 UNEVALUABLE EVENT 1 0.0000
545 DEPRESSION 3 0.0000
546 PAIN 8 0.0000
547 ARTHRITIS 1 0.0000
548 PROSTATE CANCER 1 0.0000
549 DRY MOUTH 1 0.0000
550 TREATMENT FAILURE 1 0.0000
551 MYALGIA 2 0.0000
552 BALANCE DISORDER 1 0.0000
553 PRODUCT STORAGE ERROR 1 0.0000
554 INTENTIONAL PRODUCT MISUSE 1 0.0000
555 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
556 SUICIDAL IDEATION 1 0.0000
557 MUSCLE SPASMS 2 0.0000
558 OROPHARYNGEAL PAIN 1 0.0000
559 BREAST CANCER 1 0.0000
560 BLOOD GLUCOSE INCREASED 2 0.0000
561 DYSPHAGIA 1 0.0000
562 CONDITION AGGRAVATED 3 0.0000
563 ERYTHEMA 2 0.0000
564 OVERDOSE 2 0.0000
565 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
566 ASTHMA 1 0.0000
567 NEUTROPENIA 1 0.0000
568 INFECTION 1 0.0000
569 HYPOAESTHESIA 1 0.0000
570 NASOPHARYNGITIS 1 0.0000
571 ARTHRALGIA 2 0.0000
572 DRUG INEFFECTIVE 6 0.0000
573 INJECTION SITE PAIN 1 0.0000